Status:
COMPLETED
Ibuprofen in Sepsis Study
Lead Sponsor:
Vanderbilt University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Acute Respiratory Distress Syndrome
Lung Diseases
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
To determine the effects of ibuprofen on mortality, development and reversal of shock, and adult respiratory distress syndrome, and on Lung Parenchymal Injury Score in adult patients with serious infe...
Detailed Description
BACKGROUND: The adult respiratory distress syndrome (ARDS) is a multifactorial disorder most commonly occurring secondary to sepsis syndrome. Sepsis syndrome occurs in 250,000 to 500,000 patients per...
Eligibility Criteria
Men and women patients with known or suspected sites of serious infection if core temperature was 38.3 degrees Celsius, heart rate 90 in the absence of beta-blockers, respiratory rate 20 or minute ventilation 10 liters per minute. In addition, one o
Key Trial Info
Start Date :
September 1 1990
Trial Type :
INTERVENTIONAL
End Date :
July 1 1995
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000574
Start Date
September 1 1990
End Date
July 1 1995
Last Update
February 1 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.